American Oriental Bioengr
AOB · Chemicals & Drugs · NYSE · in our data July 18, 2005 to March 15, 2012 (6.7 years)
The first trading day in our data for American Oriental Bioengr is July 18, 2005 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on October 31, 2007, the market valued it at $1.0 billion. It ended in a collapse: the last trade was $1.52, -94.5% from its split-adjusted high. The delisting record says: likely failure.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2005. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2012: Chemicals & Drugs
- Human Genome Sciences Inc peaked at $11.1 billion
- Pharmasset Inc peaked at $10.4 billion
- Amylin Pharmaceuticals Inc peaked at $6.8 billion
- Gen-probe Inc peaked at $4.2 billion
- Solutia Inc peaked at $3.5 billion
- Medicis Pharmaceut CP peaked at $2.7 billion
